Degradation of Cationized Low Density Lipoprotein and Regulation of Cholesterol Metabolism in Homozygous Familial Hypercholesterolemia Fibroblasts

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1976 Sep 1

PMID 184464

Citations 233

Authors

S K Basu

J L Goldstein

G W Anderson

M S Brown

Affiliations

Soon will be listed here.

Abstract

Cultured fibroblasts derived from patients with homozygous familial hypercholesterolemia, which lack functional low density lipoprotein (LDL) receptors, fail to bind, take up, or degrade the lipoprotein with high affinity; therefore LDL-cholesterol is not made available for suppression of cholesterol synthesis or activation of cholesteryl ester formation. When LDL was given a positive charge by reaction with N,N-dimethyl-1,3-propanediamine (cationized LDL), the rate of degradation of the lipoprotein was increased by more than 100-fold in the homozygous familial hypercholesterolemia fibroblasts. Degradation of cationized LDL was inhibited by chloroquine, suggesting that it occurred in cellular lysosomes. Although the cationized LDL entered the cell through a mechanism independent of the LDL receptor, the cholesterol liberated from the degradation of the lipoprotein became available for suppression of cholesterol synthesis and stimulation of cholesteryl ester formation in the homozygous familial hypercholesterolemia fibroblasts. The rate of degradation of albumin by fibroblasts was also increased by more than 100-fold when this protein was coupled to N,N-dimethyl-1,3-propanediamine. The ability to deliver a protein to lysosomes by giving it a strong positive charge may have potential relevance not only to familial hypercholesterolemia, but also to inborn errors of metabolism that involve deficiencies in lysosomal enzymes.

Citing Articles

MicroRNA 223 Enhances ABCA1 Protein Stability and Supports Efflux in Cholesterol-Burdened Macrophages.

Syed R, Rengasamy P, Rajagopalan S, Deiuliis J, Maiseyeu A Cell Biochem Biophys. 2024; .

PMID: 39541001 DOI: 10.1007/s12013-024-01603-3.

The Composition of the HDL Particle and Its Capacity to Remove Cellular Cholesterol Are Associated with a Reduced Risk of Developing Active Inflammatory Rheumatoid Arthritis.

Giacaglia M, Felix V, Santana M, Amendola L, Lerner P, Fernandes S Int J Mol Sci. 2024; 25(20).

PMID: 39456762 PMC: 11507075. DOI: 10.3390/ijms252010980.

Cholesterol trafficking to the ER leads to the activation of CaMKII/JNK/NLRP3 and promotes atherosclerosis.

Yalcinkaya M, Liu W, Xiao T, Abramowicz S, Wang R, Wang N J Lipid Res. 2024; 65(4):100534.

PMID: 38522750 PMC: 11031842. DOI: 10.1016/j.jlr.2024.100534.

The Prolonged Activation of the p65 Subunit of the NF-Kappa-B Nuclear Factor Sustains the Persistent Effect of Advanced Glycation End Products on Inflammatory Sensitization in Macrophages.

Assis S, Amendola L, Okamoto M, Ferreira G, Iborra R, Santos D Int J Mol Sci. 2024; 25(5).

PMID: 38473959 PMC: 10932021. DOI: 10.3390/ijms25052713.

BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in Clonal Hematopoiesis.

Yalcinkaya M, Liu W, Thomas L, Olszewska M, Xiao T, Abramowicz S Circulation. 2023; 148(22):1764-1777.

PMID: 37781816 PMC: 10872582. DOI: 10.1161/CIRCULATIONAHA.123.065344.

References

Weissmann G, Bloomgarden D, Kaplan R, Cohen C, Hoffstein S, Collins T . A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells. Proc Natl Acad Sci U S A. 1975; 72(1):88-92. PMC: 432246. DOI: 10.1073/pnas.72.1.88. View

Brown M, Dana S, Goldstein J . Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. J Biol Chem. 1975; 250(10):4025-7. View

LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

Goldstein J, Brunschede G, Brown M . Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339. J Biol Chem. 1975; 250(19):7854-62. View

Deckelbaum R, Shipley G, Small D, Lees R, George P . Thermal transitions in human plasma low density lipoproteins. Science. 1975; 190(4212):392-4. DOI: 10.1126/science.170681. View

Goldstein J, Dana S, Faust J, Beaudet A, Brown M . Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biol Chem. 1975; 250(21):8487-95. View

Brown M, Goldstein J . Receptor-mediated control of cholesterol metabolism. Science. 1976; 191(4223):150-4. DOI: 10.1126/science.174194. View

Brown M, Goldstein J . Familial hypercholesterolemia: A genetic defect in the low-density lipoprotein receptor. N Engl J Med. 1976; 294(25):1386-90. DOI: 10.1056/NEJM197606172942509. View

Goldstein J, Basu S, Brunschede G, Brown M . Release of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans. Cell. 1976; 7(1):85-95. DOI: 10.1016/0092-8674(76)90258-0. View

10.

Brown M, Goldstein J . Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell. 1975; 6(3):307-16. DOI: 10.1016/0092-8674(75)90182-8. View

11.

Goldstein J, Dana S, Brunschede G, Brown M . Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. Proc Natl Acad Sci U S A. 1975; 72(3):1092-6. PMC: 432472. DOI: 10.1073/pnas.72.3.1092. View

12.

Brown M, Dana S, Goldstein J . Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci U S A. 1975; 72(8):2925-9. PMC: 432891. DOI: 10.1073/pnas.72.8.2925. View

13.

Danon D, Goldstein L, MARIKOVSKY Y, Skutelsky E . Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res. 1972; 38(5):500-10. DOI: 10.1016/0022-5320(72)90087-1. View

14.

NOBLE R . Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968; 9(6):693-700. View

15.

Brown M, Dana S, Goldstein J . Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974; 249(3):789-96. View

16.

Brown M, Goldstein J . Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc Natl Acad Sci U S A. 1974; 71(3):788-92. PMC: 388099. DOI: 10.1073/pnas.71.3.788. View

17.

Goldstein J, Brown M . Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974; 249(16):5153-62. View

18.

Papahadjopoulos D, Mayhew E, Poste G, Smith S, Vail W . Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature. 1974; 252(5479):163-6. DOI: 10.1038/252163a0. View

19.

Goldstein J, Dana S, Brown M . Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A. 1974; 71(11):4288-92. PMC: 433867. DOI: 10.1073/pnas.71.11.4288. View

20.

Brown M, Goldstein J . Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J Biol Chem. 1974; 249(22):7306-14. View